- Home
- REX vs NXPLW Comparison
REX vs NXPLW Comparison
Compare REX & NXPLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REX
- NXPLW
- Stock Information
- Founded
- REX 1980
- NXPLW N/A
- Country
- REX United States
- NXPLW United States
- Employees
- REX N/A
- NXPLW 166
- Industry
- REX Major Chemicals
- NXPLW Telecommunications Equipment
- Sector
- REX Industrials
- NXPLW Telecommunications
- Exchange
- REX Nasdaq
- NXPLW Nasdaq
- Market Cap
- REX N/A
- NXPLW N/A
- IPO Year
- REX N/A
- NXPLW N/A
- Fundamental
- Price
- REX $40.52
- NXPLW $0.16
- Analyst Decision
- REX Strong Buy
- NXPLW
- Analyst Count
- REX 1
- NXPLW 0
- Target Price
- REX $50.00
- NXPLW N/A
- AVG Volume (30 Days)
- REX 182.3K
- NXPLW 6.4K
- Earning Date
- REX 05-21-2025
- NXPLW 03-31-2025
- Dividend Yield
- REX N/A
- NXPLW N/A
- EPS Growth
- REX N/A
- NXPLW N/A
- EPS
- REX 3.30
- NXPLW N/A
- Revenue
- REX $642,491,000.00
- NXPLW $66,482,000.00
- Revenue This Year
- REX $3.27
- NXPLW N/A
- Revenue Next Year
- REX $17.11
- NXPLW N/A
- P/E Ratio
- REX $12.25
- NXPLW N/A
- Revenue Growth
- REX N/A
- NXPLW 179.89
- 52 Week Low
- REX $33.45
- NXPLW $0.25
- 52 Week High
- REX $60.41
- NXPLW $0.26
- Technical
- Relative Strength Index (RSI)
- REX 60.92
- NXPLW N/A
- Support Level
- REX $39.62
- NXPLW N/A
- Resistance Level
- REX $41.15
- NXPLW N/A
- Average True Range (ATR)
- REX 1.62
- NXPLW 0.00
- MACD
- REX 0.30
- NXPLW 0.00
- Stochastic Oscillator
- REX 91.82
- NXPLW 0.00
About NXPLW NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.